Cosmetics and CBD: What does the legislation say?

The CBD, as an isolated molecule, is indeed authorized in France, which has been the subject of several tumultuous episodes. Indeed, its legislation has evolved over time.

• Before 2018: CBD was considered a regulated substance and subjected to strict controls in France. Its use was limited and generally reserved for specific medical purposes (decree of August 22, 1990).

• 2018: The Court of Justice of the European Union (CJEU) issued a ruling stating that CBD derived from the hemp plant should not be considered a drug and therefore should not be subject to strict restrictions.

• November 19, 2020: The CJEU rules the prohibition of member states from marketing CBD "legally produced in another member state when it is extracted from the Cannabis sativa in its entirety and not just from its fibers and seeds" as illegal. In France, the French regulation on CBD was deemed not to be compatible with European law. This has paved the way for a change in French legislation.

• December 30, 2021: A decree has been published regarding the regulation of hemp cultivation, industrial production of hemp extract, and the marketing of processed products derived from hemp in France, as well as the authorization to use CBD and other non-narcotic hemp extracts, provided they come from the stem, fibers, or seeds of the plant. It also aligned with the increase in the maximum THC level allowed in hemp plants from 0.2% to 0.3%. However, the marketing of CBD flowers and leaves intended for human consumption remained prohibited.

• January 24, 2022: After an urgent appeal from professionals and merchants in the sector, the Council of State has decided to invalidate the first paragraph II of Article 1 of the decree of December 30, 2021, through an order concerning the prohibition of selling raw flowers and leaves of only the varieties of Cannabis sativa with a THC level of 0.3% or less, meaning without any narcotic properties.

According to European regulation 1223/2009, the incorporation of narcotics into cosmetology care is not permitted. Regarding CBD, the European Court of Justice has ruled: cannabidiol is not considered a narcotic or a drug, as it lacks psychoactive properties. Thus, the sale of products containing CBD is allowed in France, to the extent that some refer to it as "legal cannabis". However, to be compliant, marketed, and made available in various forms, certain national restrictions must be followed, according to thedecree of December 30, 2021, which applies to all sectors, not just cosmetics.

• The cultivation of hemp is limited to certain authorized subspecies and varieties listed in the common European catalog, in line with the rules of the Common Agricultural Policy;

• The CBD extract cannot come from the flowering tops of the plant. It must be extracted exclusively from the seeds and leaves of Cannabis sativa ;

• Hemp extracts, as well as CBD-based products, must have a threshold of THC that does not exceed 0.3%. Otherwise, they fall under the criminal policy against narcotics;

• If THC is present as an impurity in the initial extract, its concentration and toxicity must be analyzed in the product information file (PIF) by the safety assessor.

• Products containing CBD, under penalty of criminal sanctions, cannot make therapeutic claimsunless they have been authorized as a medication, and above all, they must adhere to the Common Criteria dictated by the Cosmetic Regulation.

Our CBD capsule is formulated in France from the leaves, and meets national standards.